_id
690f34a0ccc777a4e85d1687
Ticker
BFRIW
Name
Biofrontera Inc. Warrants
Exchange
NASDAQ
Address
120 Presidential Way, Woburn, MA, United States, 01801
Country
USA
Sector
Industry
Currency
USD
Website
https://www.biofrontera-us.com
Description
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Last Close
0.0971
Volume
1424
Current Price
0.0513
Change
-0.01
Last Updated
2026-01-19T10:35:50.568Z
Image
data:image/webp;base64,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
Ipo Date
2021-10-29T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
6988000
Cost Of Revenue
1922000
Gross Profit
5066000
Operating Expenses
11344000
Operating Income
-6278000
Interest Expense
111000
Pretax Income
-6643000
Net Income
-6649000
Eps
-0.6169769909060616
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
6000
EBITDA
-6333000
Operating Margin
-89.83972524327419
Total Other Income Expense Net
-365000
Cash
3417000
Short Term Investments
10000
Receivables
2995000
Inventories
4329000
Total Current Assets
14413000
Property Plant Equipment
508000
Total Assets
15415000
Payables
3639000
Short Term Debt
307000
Long Term Debt
4462000
Total Liabilities
17996000
Equity
-2581000
Bs_currency_symbol
USD
Depreciation
207000
Change In Working Capital
1955000
Cash From Operations
-3823000
Capital Expenditures
1000
Cash From Investing
1000
Cash From Financing
0
Net Change In Cash
-3822000
Cf_currency_symbol
USD
PE
-
PB
-0.2141986480821387
ROE
257.61332816737695
ROA
-43.133311709373984
FCF
-3824000
Fcf Percent
-0.5472238122495707
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
5
Net Net Investing Score
0
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
6988000
Quarters > 0 > income Statement > cost Of Revenue
1922000
Quarters > 0 > income Statement > gross Profit
5066000
Quarters > 0 > income Statement > operating Expenses
11344000
Quarters > 0 > income Statement > operating Income
-6278000
Quarters > 0 > income Statement > interest Expense
111000
Quarters > 0 > income Statement > pretax Income
-6643000
Quarters > 0 > income Statement > net Income
-6649000
Quarters > 0 > income Statement > eps
-0.6169769909060616
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10776739
Quarters > 0 > income Statement > income Tax Expense
6000
Quarters > 0 > income Statement > EBITDA
-6333000
Quarters > 0 > income Statement > operating Margin
-89.83972524327419
Quarters > 0 > income Statement > total Other Income Expense Net
-365000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
3417000
Quarters > 0 > balance Sheet > short Term Investments
10000
Quarters > 0 > balance Sheet > receivables
2995000
Quarters > 0 > balance Sheet > inventories
4329000
Quarters > 0 > balance Sheet > total Current Assets
14413000
Quarters > 0 > balance Sheet > property Plant Equipment
508000
Quarters > 0 > balance Sheet > total Assets
15415000
Quarters > 0 > balance Sheet > payables
3639000
Quarters > 0 > balance Sheet > short Term Debt
307000
Quarters > 0 > balance Sheet > long Term Debt
4462000
Quarters > 0 > balance Sheet > total Liabilities
17996000
Quarters > 0 > balance Sheet > equity
-2581000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-6649000
Quarters > 0 > cash Flow > depreciation
207000
Quarters > 0 > cash Flow > change In Working Capital
1955000
Quarters > 0 > cash Flow > cash From Operations
-3823000
Quarters > 0 > cash Flow > capital Expenditures
1000
Quarters > 0 > cash Flow > cash From Investing
1000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-3822000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6169769909060616
Quarters > 0 > ratios > PB
-0.2141986480821387
Quarters > 0 > ratios > ROE
257.61332816737695
Quarters > 0 > ratios > ROA
-43.133311709373984
Quarters > 0 > ratios > FCF
-3824000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.5472238122495707
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
9030000
Quarters > 1 > income Statement > cost Of Revenue
2380000
Quarters > 1 > income Statement > gross Profit
6650000
Quarters > 1 > income Statement > operating Expenses
11729000
Quarters > 1 > income Statement > operating Income
-5079000
Quarters > 1 > income Statement > interest Expense
115000
Quarters > 1 > income Statement > pretax Income
-5303000
Quarters > 1 > income Statement > net Income
-5324000
Quarters > 1 > income Statement > eps
-0.5693169597319463
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
9351557
Quarters > 1 > income Statement > income Tax Expense
21000
Quarters > 1 > income Statement > EBITDA
-4966000
Quarters > 1 > income Statement > operating Margin
-56.245847176079735
Quarters > 1 > income Statement > total Other Income Expense Net
-224000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
7239000
Quarters > 1 > balance Sheet > short Term Investments
9000
Quarters > 1 > balance Sheet > receivables
3955000
Quarters > 1 > balance Sheet > inventories
4027999
Quarters > 1 > balance Sheet > total Current Assets
18815000
Quarters > 1 > balance Sheet > property Plant Equipment
766000
Quarters > 1 > balance Sheet > total Assets
20142000
Quarters > 1 > balance Sheet > payables
4938000
Quarters > 1 > balance Sheet > short Term Debt
443000
Quarters > 1 > balance Sheet > long Term Debt
4338000
Quarters > 1 > balance Sheet > total Liabilities
24810000
Quarters > 1 > balance Sheet > equity
-4668000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5324000
Quarters > 1 > cash Flow > depreciation
222000
Quarters > 1 > cash Flow > change In Working Capital
1916000
Quarters > 1 > cash Flow > cash From Operations
-3045000
Quarters > 1 > cash Flow > capital Expenditures
1000
Quarters > 1 > cash Flow > cash From Investing
-1000
Quarters > 1 > cash Flow > cash From Financing
8500000
Quarters > 1 > cash Flow > net Change In Cash
5454000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5693169597319463
Quarters > 1 > ratios > PB
-0.10277096703084833
Quarters > 1 > ratios > ROE
114.05312767780633
Quarters > 1 > ratios > ROA
-26.432330453778174
Quarters > 1 > ratios > FCF
-3046000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.33732004429678847
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
8588000
Quarters > 2 > income Statement > cost Of Revenue
3075000
Quarters > 2 > income Statement > gross Profit
5513000
Quarters > 2 > income Statement > operating Expenses
10060000
Quarters > 2 > income Statement > operating Income
-4547000
Quarters > 2 > income Statement > interest Expense
120000
Quarters > 2 > income Statement > pretax Income
-4204000
Quarters > 2 > income Statement > net Income
-4203000
Quarters > 2 > income Statement > eps
-0.7619190571129304
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5516334
Quarters > 2 > income Statement > income Tax Expense
-1000
Quarters > 2 > income Statement > EBITDA
-3865000
Quarters > 2 > income Statement > operating Margin
-52.9459711224965
Quarters > 2 > income Statement > total Other Income Expense Net
343000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1785000
Quarters > 2 > balance Sheet > short Term Investments
7000
Quarters > 2 > balance Sheet > receivables
4031000
Quarters > 2 > balance Sheet > inventories
6527000
Quarters > 2 > balance Sheet > total Current Assets
15332000
Quarters > 2 > balance Sheet > property Plant Equipment
772000
Quarters > 2 > balance Sheet > total Assets
16588000
Quarters > 2 > balance Sheet > payables
3300000
Quarters > 2 > balance Sheet > short Term Debt
426000
Quarters > 2 > balance Sheet > long Term Debt
4217000
Quarters > 2 > balance Sheet > total Liabilities
16119000
Quarters > 2 > balance Sheet > equity
469000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4203000
Quarters > 2 > cash Flow > depreciation
219000
Quarters > 2 > cash Flow > change In Working Capital
103000
Quarters > 2 > cash Flow > cash From Operations
-4117000
Quarters > 2 > cash Flow > capital Expenditures
3000
Quarters > 2 > cash Flow > cash From Investing
-3000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-4120000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.7619190571129304
Quarters > 2 > ratios > PB
0.603385787206823
Quarters > 2 > ratios > ROE
-896.1620469083156
Quarters > 2 > ratios > ROA
-25.33759344104172
Quarters > 2 > ratios > FCF
-4120000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.47973917093619
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
12559000
Quarters > 3 > income Statement > cost Of Revenue
5272000
Quarters > 3 > income Statement > gross Profit
7287000
Quarters > 3 > income Statement > operating Expenses
8999000
Quarters > 3 > income Statement > operating Income
-1712000
Quarters > 3 > income Statement > interest Expense
55000
Quarters > 3 > income Statement > pretax Income
-1399000
Quarters > 3 > income Statement > net Income
-1396000
Quarters > 3 > income Statement > eps
-0.25306661996898666
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5516334
Quarters > 3 > income Statement > income Tax Expense
-3000
Quarters > 3 > income Statement > EBITDA
-1123000
Quarters > 3 > income Statement > operating Margin
-13.63165857154232
Quarters > 3 > income Statement > total Other Income Expense Net
313000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5905000
Quarters > 3 > balance Sheet > short Term Investments
7000
Quarters > 3 > balance Sheet > receivables
5315000
Quarters > 3 > balance Sheet > inventories
6646000
Quarters > 3 > balance Sheet > total Current Assets
20700000
Quarters > 3 > balance Sheet > property Plant Equipment
983000
Quarters > 3 > balance Sheet > total Assets
22101000
Quarters > 3 > balance Sheet > payables
1856000
Quarters > 3 > balance Sheet > short Term Debt
548000
Quarters > 3 > balance Sheet > long Term Debt
4098000
Quarters > 3 > balance Sheet > total Liabilities
17668000
Quarters > 3 > balance Sheet > equity
4433000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1396000
Quarters > 3 > cash Flow > depreciation
221000
Quarters > 3 > cash Flow > change In Working Capital
108000
Quarters > 3 > cash Flow > cash From Operations
-1017000
Quarters > 3 > cash Flow > capital Expenditures
1000
Quarters > 3 > cash Flow > cash From Investing
-1000
Quarters > 3 > cash Flow > cash From Financing
4050000
Quarters > 3 > cash Flow > net Change In Cash
3032000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.25306661996898666
Quarters > 3 > ratios > PB
0.06383666460636138
Quarters > 3 > ratios > ROE
-31.491089555605683
Quarters > 3 > ratios > ROA
-6.316456268947107
Quarters > 3 > ratios > FCF
-1018000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.08105740902938131
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
37303000
Annuals > 0 > income Statement > cost Of Revenue
18607000
Annuals > 0 > income Statement > gross Profit
18696000
Annuals > 0 > income Statement > operating Expenses
35924000
Annuals > 0 > income Statement > operating Income
-17210000
Annuals > 0 > income Statement > interest Expense
2106000
Annuals > 0 > income Statement > pretax Income
-17737000
Annuals > 0 > income Statement > net Income
-17759000
Annuals > 0 > income Statement > eps
-3.219348212055325
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5516334
Annuals > 0 > income Statement > income Tax Expense
22000
Annuals > 0 > income Statement > EBITDA
-14441000
Annuals > 0 > income Statement > operating Margin
-46.135699541591826
Annuals > 0 > income Statement > total Other Income Expense Net
-527000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5905000
Annuals > 0 > balance Sheet > short Term Investments
7000
Annuals > 0 > balance Sheet > receivables
5315000
Annuals > 0 > balance Sheet > inventories
6646000
Annuals > 0 > balance Sheet > total Current Assets
20700000
Annuals > 0 > balance Sheet > property Plant Equipment
983000
Annuals > 0 > balance Sheet > total Assets
22101000
Annuals > 0 > balance Sheet > payables
1856000
Annuals > 0 > balance Sheet > short Term Debt
548000
Annuals > 0 > balance Sheet > long Term Debt
4098000
Annuals > 0 > balance Sheet > total Liabilities
17668000
Annuals > 0 > balance Sheet > equity
4433000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-17759000
Annuals > 0 > cash Flow > depreciation
1149000
Annuals > 0 > cash Flow > change In Working Capital
6212000
Annuals > 0 > cash Flow > cash From Operations
-10270000
Annuals > 0 > cash Flow > capital Expenditures
60000
Annuals > 0 > cash Flow > cash From Investing
-3000
Annuals > 0 > cash Flow > cash From Financing
14835000
Annuals > 0 > cash Flow > net Change In Cash
4562000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.219348212055325
Annuals > 0 > ratios > PB
0.06383666460636138
Annuals > 0 > ratios > ROE
-400.6090683510038
Annuals > 0 > ratios > ROA
-80.35383014343242
Annuals > 0 > ratios > FCF
-10330000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.2769214272310538
Annuals > 0 > health Score
15
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
34071000
Annuals > 1 > income Statement > cost Of Revenue
17444000
Annuals > 1 > income Statement > gross Profit
16627000
Annuals > 1 > income Statement > operating Expenses
39304000
Annuals > 1 > income Statement > operating Income
-22677000
Annuals > 1 > income Statement > interest Expense
600000
Annuals > 1 > income Statement > pretax Income
-20117000
Annuals > 1 > income Statement > net Income
-20131000
Annuals > 1 > income Statement > eps
-13.01884437465765
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1546297
Annuals > 1 > income Statement > income Tax Expense
14000
Annuals > 1 > income Statement > EBITDA
-18453000
Annuals > 1 > income Statement > operating Margin
-66.55806991282908
Annuals > 1 > income Statement > total Other Income Expense Net
2560000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1343000
Annuals > 1 > balance Sheet > short Term Investments
78000
Annuals > 1 > balance Sheet > receivables
5162000
Annuals > 1 > balance Sheet > inventories
10908000
Annuals > 1 > balance Sheet > total Current Assets
23075000
Annuals > 1 > balance Sheet > property Plant Equipment
1746000
Annuals > 1 > balance Sheet > total Assets
27932000
Annuals > 1 > balance Sheet > payables
8906000
Annuals > 1 > balance Sheet > short Term Debt
4595000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
23139000
Annuals > 1 > balance Sheet > equity
4793000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-20131000
Annuals > 1 > cash Flow > depreciation
1064000
Annuals > 1 > cash Flow > change In Working Capital
-4394000
Annuals > 1 > cash Flow > cash From Operations
-24895000
Annuals > 1 > cash Flow > capital Expenditures
5000
Annuals > 1 > cash Flow > cash From Investing
619000
Annuals > 1 > cash Flow > cash From Financing
8411000
Annuals > 1 > cash Flow > net Change In Cash
-15865000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-13.01884437465765
Annuals > 1 > ratios > PB
0.016550184873774253
Annuals > 1 > ratios > ROE
-420.0083455038598
Annuals > 1 > ratios > ROA
-72.07145925819847
Annuals > 1 > ratios > FCF
-24900000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.730826802852866
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
28674000
Annuals > 2 > income Statement > cost Of Revenue
15185000
Annuals > 2 > income Statement > gross Profit
13489000
Annuals > 2 > income Statement > operating Expenses
32070000
Annuals > 2 > income Statement > operating Income
-18581000
Annuals > 2 > income Statement > interest Expense
370000
Annuals > 2 > income Statement > pretax Income
-608000
Annuals > 2 > income Statement > net Income
-640000
Annuals > 2 > income Statement > eps
-0.6054941021090117
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1056988
Annuals > 2 > income Statement > income Tax Expense
32000
Annuals > 2 > income Statement > EBITDA
934000
Annuals > 2 > income Statement > operating Margin
-64.80086489502685
Annuals > 2 > income Statement > total Other Income Expense Net
17973000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
17208000
Annuals > 2 > balance Sheet > short Term Investments
10548000
Annuals > 2 > balance Sheet > receivables
7406000
Annuals > 2 > balance Sheet > inventories
7168000
Annuals > 2 > balance Sheet > total Current Assets
43140000
Annuals > 2 > balance Sheet > property Plant Equipment
1579000
Annuals > 2 > balance Sheet > total Assets
50884000
Annuals > 2 > balance Sheet > payables
1278000
Annuals > 2 > balance Sheet > short Term Debt
498000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
27006000
Annuals > 2 > balance Sheet > equity
23878000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-640000
Annuals > 2 > cash Flow > depreciation
1172000
Annuals > 2 > cash Flow > change In Working Capital
2788000
Annuals > 2 > cash Flow > cash From Operations
-16199000
Annuals > 2 > cash Flow > capital Expenditures
38000
Annuals > 2 > cash Flow > cash From Investing
-5156000
Annuals > 2 > cash Flow > cash From Financing
14021000
Annuals > 2 > cash Flow > net Change In Cash
-7334000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.6054941021090117
Annuals > 2 > ratios > PB
0.0022708553647709188
Annuals > 2 > ratios > ROE
-2.6802914816986347
Annuals > 2 > ratios > ROA
-1.2577627545004324
Annuals > 2 > ratios > FCF
-16237000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.5662621189928158
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
24100000
Annuals > 3 > income Statement > cost Of Revenue
12742000
Annuals > 3 > income Statement > gross Profit
11358000
Annuals > 3 > income Statement > operating Expenses
36559000
Annuals > 3 > income Statement > operating Income
-25201000
Annuals > 3 > income Statement > interest Expense
360000
Annuals > 3 > income Statement > pretax Income
-37657000
Annuals > 3 > income Statement > net Income
-37713000
Annuals > 3 > income Statement > eps
-44.09654867598104
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
855237
Annuals > 3 > income Statement > income Tax Expense
56000
Annuals > 3 > income Statement > EBITDA
-36757000
Annuals > 3 > income Statement > operating Margin
-104.56846473029047
Annuals > 3 > income Statement > total Other Income Expense Net
-12456000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
24545000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
3784000
Annuals > 3 > balance Sheet > inventories
4458000
Annuals > 3 > balance Sheet > total Current Assets
46421000
Annuals > 3 > balance Sheet > property Plant Equipment
267000
Annuals > 3 > balance Sheet > total Assets
53219000
Annuals > 3 > balance Sheet > payables
658000
Annuals > 3 > balance Sheet > short Term Debt
6694000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
41881000
Annuals > 3 > balance Sheet > equity
11338000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-37713000
Annuals > 3 > cash Flow > depreciation
540000
Annuals > 3 > cash Flow > change In Working Capital
-1505000
Annuals > 3 > cash Flow > cash From Operations
-26715000
Annuals > 3 > cash Flow > capital Expenditures
11000
Annuals > 3 > cash Flow > cash From Investing
-11000
Annuals > 3 > cash Flow > cash From Financing
43191000
Annuals > 3 > cash Flow > net Change In Cash
16465000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-44.09654867598104
Annuals > 3 > ratios > PB
0.00386961175692362
Annuals > 3 > ratios > ROE
-332.62480155230196
Annuals > 3 > ratios > ROA
-70.86378924820083
Annuals > 3 > ratios > FCF
-26726000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.1089626556016599
Annuals > 3 > health Score
15
Valuation > metrics > PE
-0.6169769909060616
Valuation > metrics > PB
-0.2141986480821387
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
257.61332816737695
Profitability > metrics > ROA
-46.13196419898703
Profitability > metrics > Net Margin
-0.9514882655981682
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-56.55855855855856
Risk > final Score
-196
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.652559553978713
Liquidity > metrics > Quick Ratio
2.555499239736442
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-147
Prev Risks > 1
-146
Prev Risks > 2
-119
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:29:01.776Z
Earnings History > 0 > period
2021-03-31
Earnings History > 0 > report Date
2021-06-30
Earnings History > 0 > date
2021-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.4576
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.4576
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2020-12-31
Earnings History > 1 > report Date
2021-03-31
Earnings History > 1 > date
2020-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.4418
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.4418
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-09-30
Earnings History > 2 > report Date
2020-12-31
Earnings History > 2 > date
2020-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.1982
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.1982
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-06-30
Earnings History > 3 > report Date
2020-09-30
Earnings History > 3 > date
2020-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.1982
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.1982
Earnings History > 3 > surprise Percent
-
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABreakout Zone: What analysts say about CWBC stock - Weekly Profit Recap & AI Enhanced Trading Signals baoquankhu1.vn
Read more →Showing 2 of 8
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Biofrontera Inc. Warrants
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.4576
EPS Estimate
0
EPS Difference
-0.4576
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.